potential partner, page-3

Sillazze post translated

Good morning,

just now I come across a news of October 30 last that concerns Senofi. read the two news stories respectively as your starting point and point of arrival:

https://www.fiercebiotech.com/partnering/sanofi-embarks-on-an-845m-gene-therapy-r-d-odyssey-voyager

https://endpts.com/sanofi-genzyme-r...therapy-upstart-voyager-part-of-an-845m-pact/

in October 2015 I and my friend Hottod tried to think about what was evolving in Neuren about the real estate patent FX trial and the strong connection with NNZ-2591 which we know to be the true Neuren diamond with interests also from part of US military.

I am very surprised at Sanofi's new tale that in the last annual report of April 28 last page 3 for the first time I refer to ATAXIA with FX. at the time it was a surprise to us that for the way Neuren acts is not at all casual.
Looks like the NEU title after a long time in the area of 0.06 / 0.07 since October 30 raises the rod without delay and performs to 150% today. mahhhh .....

to better understand and be able to make a more thorough reflection on the link of October 2015 regarding my post with the contribution of Hottod:

https://hotcopper.com.au/threads/senofi-partnership.2620564/

good luck